The Board of Directors of Catheter Precision, Inc. approved an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to…
Catheter Precision, Inc. (VTAK) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On September 24, 2026, the Board of Directors (the “Board”) of Catheter Precision, Inc. (the “Company”) approved an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to (i) change the Company's name from “Catheter Pr
How this was made
The 30-second read
Why it matters
The split will adjust share counts and may affect market depth; the name change will rebrand the company, possibly attracting new investor interest in the aviation sector.
Market read
Primary corporate action for a micro‑cap; immediate relevance for traders holding or shorting VTAK.
What to watch
Potential confusion with the new ticker VJET may cause temporary mispricing; monitor order flow on both symbols.
Background
Catheter Precision, Inc. filed an 8‑K announcing a corporate restructuring: a name change to Flyte Aviation, Inc. and a 1‑for‑10 reverse split of its common stock.
Ticker impact
SEC 8‑K reports a name change to Flyte Aviation and a 1‑for‑10 reverse stock split effective Oct 5 2026.
Potential short‑term swing of ±5% as market digests the split and new ticker rollout.
Corporate actions of this nature are typically priced in quickly; traders must update order sizes and monitor liquidity on the new ticker.
Market effects
No immediate sector impact; only the company's own shares are affected.
Limited to U.S. small‑cap investors tracking NYSE American listings.
Minimal global relevance beyond the name‑change and split.
Counterpoint
If the split triggers a liquidity squeeze, short sellers could be forced to cover, creating a brief upside.
Key entities
- companyCatheter Precision, Inc.
Issuer of the 8‑K filing, currently trading under VTAK.
- companyFlyte Aviation, Inc.
Future name of the issuer post‑effective date.